634 related articles for article (PubMed ID: 17596796)
1. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
[TBL] [Abstract][Full Text] [Related]
2. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of subcutaneous versus intramuscular Oka/Merck varicella vaccination in healthy children.
Dennehy PH; Reisinger KS; Blatter MM; Veloudis BA
Pediatrics; 1991 Sep; 88(3):604-7. PubMed ID: 1881743
[TBL] [Abstract][Full Text] [Related]
4. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
5. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
6. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
[TBL] [Abstract][Full Text] [Related]
7. Antibody response after varicella vaccination in children treated with budesonide inhalation suspension or non-steroidal conventional asthma therapy.
Murphy K; Ververeli K; Harvey BM; Duke AL; Chapas-Crilly J; Uryniak T; Lyzell E; Mezzanotte W
Int J Clin Pract; 2006 Dec; 60(12):1548-57. PubMed ID: 17109664
[TBL] [Abstract][Full Text] [Related]
8. A role for genetics in the immune response to the varicella vaccine.
Klein NP; Fireman B; Enright A; Ray P; Black S; Dekker CL;
Pediatr Infect Dis J; 2007 Apr; 26(4):300-5. PubMed ID: 17414391
[TBL] [Abstract][Full Text] [Related]
9. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
11. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection.
Li S; Chan IS; Matthews H; Heyse JF; Chan CY; Kuter BJ; Kaplan KM; Vessey SJ; Sadoff JC
Pediatr Infect Dis J; 2002 Apr; 21(4):337-42. PubMed ID: 12075766
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
Kerzner B; Murray AV; Cheng E; Ifle R; Harvey PR; Tomlinson M; Barben JL; Rarrick K; Stek JE; Chung MO; Schödel FP; Wang WW; Xu J; Chan IS; Silber JL; Schlienger K
J Am Geriatr Soc; 2007 Oct; 55(10):1499-507. PubMed ID: 17908055
[TBL] [Abstract][Full Text] [Related]
13. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
[TBL] [Abstract][Full Text] [Related]
14. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
15. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
[TBL] [Abstract][Full Text] [Related]
16. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children.
Krause PR; Klinman DM
Nat Med; 2000 Apr; 6(4):451-4. PubMed ID: 10742154
[TBL] [Abstract][Full Text] [Related]
17. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.
Vessey SJ; Chan CY; Kuter BJ; Kaplan KM; Waters M; Kutzler DP; Carfagno PA; Sadoff JC; Heyse JF; Matthews H; Li S; Chan IS
J Pediatr; 2001 Aug; 139(2):297-304. PubMed ID: 11487760
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
19. Varicella immunity in vaccinated healthcare workers.
Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
[TBL] [Abstract][Full Text] [Related]
20. Varicella immunity: persistent serologic non-response to immunization.
Katial RK; Ratto-Kim S; Sitz KV; Moriarity R; Engler RJ
Ann Allergy Asthma Immunol; 1999 May; 82(5):431-4. PubMed ID: 10353572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
